LIMITED LAUNCH EDITION: MARCH BATCH — 85% CLAIMED!

Nootropics

BENEFITS OF NICOTINE POUCHES: WHAT THE RESEARCH ACTUALLY SHOWS

R

Roon Team

March 25, 20269 min read
Benefits of Nicotine Pouches: What the Research Actually Shows

Benefits of Nicotine Pouches: What the Research Actually Shows

The benefits of nicotine pouches are one of the most searched topics in the tobacco alternatives space, and for good reason. Nicotine pouches are a $3+ billion market, growing at a rate that makes most consumer categories look stagnant. The appeal is obvious: no smoke, no spit, no tobacco leaf. But when people search for the "benefits of nicotine pouches," they're usually asking a more specific question. Are nicotine pouches good for you, or just less bad than cigarettes?

The answer is more complicated than the marketing suggests. Here's what the science says about the benefits of nicotine pouches, where the major brands stack up, and what the research leaves out.

Key Takeaways

  • Nicotine pouches are less harmful than cigarettes, but that's a low bar. The FDA has authorized specific products (like ZYN) for sale, finding fewer risks than combustible tobacco, but has not declared them safe.
  • Nicotine itself carries real cardiovascular risks, including elevated heart rate and blood pressure, regardless of the delivery method.
  • Every major pouch brand still delivers nicotine, which means dependence, tolerance, and withdrawal are part of the deal, limiting the true benefits of nicotine pouches.
  • Alternatives exist that deliver the focus and energy people actually want from nicotine, without the nicotine itself.

What "Benefits of Nicotine Pouches" Actually Means in Context

Most articles about nicotine pouch benefits frame the conversation around harm reduction. And that framing matters. The "benefit" isn't that pouches make you healthier. It's that, for existing smokers, the benefits of nicotine pouches may include reduced exposure to specific carcinogens found in combustible tobacco.

A 2025 scoping review in Nicotine & Tobacco Research examined the potential public health impact of oral nicotine pouches (ONPs). The review found that while ONPs expose users to fewer toxicants than cigarettes, the long-term health effects remain largely unknown. The authors noted that widespread adoption among people who don't already use nicotine could actually reduce the net public health benefit.

A separate 2024 review published on PubMed reached a similar conclusion: ONPs have qualities, like flavors and "tobacco free" marketing, that could increase appeal among youth and young adults. These products deliver nicotine at levels sufficient to cause dependence, which complicates any discussion of nicotine pouch benefits.

So are nicotine pouches good for you? If you're comparing them to a pack of Marlboros, the answer is probably yes. If you're comparing them to not using nicotine at all, the math changes fast.

The FDA's Position (It's Nuanced)

In January 2025, the FDA authorized 20 ZYN nicotine pouch products for sale through the premarket tobacco product application (PMTA) pathway following an extensive scientific review. Swedish Match (ZYN's manufacturer) has also submitted modified risk tobacco product (MRTP) applications, seeking permission to market ZYN with reduced-risk claims. A Tobacco Products Scientific Advisory Committee (TPSAC) meeting was held in January 2026 to discuss those applications publicly.

This matters because MRTP status would allow ZYN to advertise that switching from cigarettes to their pouches reduces health risks. That's a specific, regulated claim about the benefits of nicotine pouches, and the FDA hasn't granted it yet.

But even the existing PMTA authorization isn't an endorsement. As MD Anderson Cancer Center notes, this approval "doesn't mean that nicotine pouches are safe for everyone." For young people or those who don't already use tobacco, nicotine pouches could begin a nicotine addiction. According to the 2024 National Youth Tobacco Survey, nicotine pouches are already the second most used tobacco product among high school students.

The American Cancer Society echoed this, stating that the FDA found specific nicotine pouches have "fewer risks for serious health conditions than other tobacco products." Fewer risks. Not no risks. That distinction is central to understanding whether the benefits of nicotine pouches hold up under scrutiny.

The Nicotine Problem That Limits the Benefits of Nicotine Pouches

Here's where the conversation about nicotine pouch benefits gets uncomfortable. Nicotine, independent of tobacco, is not a benign substance.

According to a policy statement from the American Heart Association, sustained nicotine exposure keeps resting heart rate higher than in non-users. Research published in PMC shows that nicotine, regardless of delivery method (smoke, gum, pouch, or IV), causes acute increases in blood pressure of 5-10 mm Hg and a greater than 150% increase in epinephrine levels.

These aren't theoretical concerns. They're measured, replicated cardiovascular effects. And they apply to every nicotine pouch on the market, directly undermining the benefits of nicotine pouches for anyone seeking a truly healthy alternative.

Then there's tolerance. Your body adapts to nicotine. The alertness and focus you felt from your first pouch? You'll need more nicotine to get the same effect within weeks. Research from Science Advances describes a daily cycle in regular nicotine users: nicotine levels rise, substantial tolerance develops during the day, and continued use occurs primarily to relieve withdrawal symptoms rather than to gain any performance benefit. That's not a feature. It's the definition of dependence.

Comparing the Major Nicotine Pouch Brands

If you're evaluating the benefits of nicotine pouches across brands, here's how the top options compare on the basics:

FeatureZYNVELO PlusOn!
Nicotine SourceExtracted from tobaccoSynthetic nicotineExtracted from tobacco
Strengths Available3mg, 6mg2mg, 4mg, 7mg2mg, 4mg, 8mg
FlavorsCool Mint, Citrus, Coffee, Peppermint, Wintergreen + moreMint, Citrus, Dragon Fruit, Berry + moreWintergreen, Mint, Cinnamon, Coffee + more
Approximate Price/Can$4-5~$4.19+$3-4
FDA PMTA AuthorizedYes (Jan 2025)Select productsSelect products
Contains NicotineYesYesYes
Tobacco-Leaf FreeYesYesYes

All three brands share the same core proposition: tobacco-leaf-free nicotine delivery. ZYN's ingredients include fillers like microcrystalline cellulose, maltitol, and gum arabic, plus pH adjusters (sodium carbonate and sodium bicarbonate) to improve nicotine absorption. On! uses similar ingredients, including hydroxypropyl cellulose as a binding agent and sodium carbonate for pH regulation.

VELO Plus differentiates itself with synthetic nicotine rather than tobacco-derived nicotine, and uses a more durable pouch material introduced in 2024.

The differences between these brands are real but marginal. Flavor variety, pouch size, nicotine source. What they all share is more telling: every single one delivers nicotine, and every single one carries the dependence and cardiovascular trade-offs that come with it. The nicotine pouch benefits remain limited by the active ingredient itself.

What's Missing From Every Nicotine Pouch

After reviewing the research and the products, a clear pattern emerges. The gaps across all major nicotine pouch brands are consistent, and they reveal the ceiling on the benefits of nicotine pouches:

1. They all create dependence. Nicotine is addictive. Full stop. Whether it's extracted from tobacco or synthesized in a lab, the molecule binds to the same receptors and triggers the same tolerance cycle. You will need more over time to get the same cognitive effect.

2. They offer no cognitive stack. People reach for nicotine pouches because they want focus, alertness, and sustained mental energy. But nicotine is a blunt instrument for cognition. It provides a short spike in attention followed by a withdrawal dip that sends you back to the can. None of these products contain complementary compounds designed to smooth out the experience or extend the duration.

3. Cardiovascular trade-offs are baked in. Elevated heart rate and blood pressure are pharmacological effects of nicotine itself. No amount of product engineering can remove them while keeping nicotine as the active ingredient. This is a hard limit on the benefits of nicotine pouches.

4. The "benefit" ceiling is low. The best-case scenario for nicotine pouches is "less harmful than smoking." That's the ceiling. The products aren't designed to optimize cognitive performance. They're designed to deliver nicotine in a cleaner format.

5. No off-ramp. If you decide you want the focus without the dependence, nicotine pouches don't offer a transition path. You either keep using nicotine or you quit and deal with withdrawal. Are nicotine pouches good for you in that scenario? The answer speaks for itself.

A Different Approach to the Same Problem

The reason most people try nicotine pouches isn't because they love nicotine. It's because they want to think more clearly, stay locked in during long work sessions, and avoid the crash that comes with coffee or energy drinks. Nicotine just happens to be the compound that's been marketed for that purpose. The benefits of nicotine pouches, in practice, are really about cognitive performance, not nicotine itself.

But the cognitive effects people are chasing (sustained focus, clean energy, no crash) don't require nicotine at all.

Roon was designed around this exact gap. It's a zero-nicotine sublingual pouch built on four compounds that work together:

  • Caffeine (40mg): Roughly half a cup of coffee. Enough to sharpen attention without the jittery overcorrection of a double espresso.
  • L-Theanine: An amino acid found in tea. A study published on PubMed found that 97mg of L-Theanine combined with 40mg of caffeine helped subjects focus attention during a demanding cognitive task. That's almost the exact dose ratio in Roon.
  • Theacrine: Structurally similar to caffeine, but research suggests it doesn't produce the same tolerance buildup. That means the effect on day 30 feels like the effect on day 1.
  • Methylliberine: Works alongside theacrine to extend the duration of the cognitive effect, supporting 4-6 hours of sustained focus rather than a short spike and crash.

The delivery method is sublingual, the same as nicotine pouches. The format is familiar. What's different is what's inside: no nicotine, no dependence pathway, no cardiovascular spike, and a duration that doesn't end with a craving. For anyone weighing the benefits of nicotine pouches against a nicotine-free option, the comparison is worth examining closely.

How Roon Addresses Each Gap

Gap in Nicotine PouchesHow Roon Addresses It
Creates dependenceZero nicotine. No addictive compounds.
No cognitive stackFour complementary ingredients designed for sustained focus
Cardiovascular side effectsNo nicotine-driven heart rate or blood pressure increases
Tolerance buildupTheacrine and methylliberine resist tolerance adaptation
No off-ramp from nicotineCan be used as a nicotine-free alternative in the same format

This isn't about being "better" than nicotine pouches in some abstract sense. It's about solving the actual problem. The benefits of nicotine pouches top out at harm reduction. If what you want is focus and sustained mental energy, and what you don't want is another substance you can't stop using, the ingredients matter more than the format.

You can learn more about how it works at takeroon.com.

Share:

READY TO UNLOCK YOUR FOCUS?

Subscribe for exclusive discounts and more content like this delivered to your inbox.

Early access 20% off first order New posts & tips